Afuco™ Anti-CTGF ADCC Therapeutic Antibody (Pamrevlumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CTGF. Pamrevlumab is a human monoclonal antibody that can be potentially used in the treatment of Duchenne muscular dystrophy, Hepatic fibrosis, Idiopathic pulmonary fibrosis, Pancreatic cancer. It inhibits connective tissue growth factor (CTGF).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-443CQ |
| Pricing | Inquiry |
| Host | Human |
| Target | CTGF |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, IHC, FC, IP, IF, Inhib |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |